• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Agenda - Public Workshop on Current Status of Useful Written Prescription Drug Information for Patients. February 29 - March 1, 2000, Rockville, MD.

Day 1
1:00 - 1:30 Moderator Nancy M. Ostrove, Ph.D.
FDA, CDER, Branch Chief Division of Drug Marketing, Advertising, and Communications
   Welcome Nancy Smith, Ph.D.
FDA, CDER, Director
Office of Training and
Communication
  Why are we here? Thomas J. McGinnis, R.Ph.
FDA, Office of Policy
Director of Pharmacy Affairs
1:30 - 1:45 History of Recent Private-Sector Information Provision Efforts Judith O'Brien
The Keystone Center
1:45 - 2:00 Background on the Patient Information Project Karen Oster
National Association of Boards of Pharmacy
2:00 - 3:00 1999 Patient Information Assessment Bonnie Svarstad, Ph.D.
Professor of Pharmacy
University of Wisconsin
3:00 -3:15 Break  
3:15 - 5:00 Assessment, cont. Dr. Svarstad
5:00 - 5:30 Questions from the audience Nancy M. Ostrove
     
Day 2
8:30 - 9:00 Continental Breakfast  
9:00 - 9:30 Welcome Nancy M. Ostrove
  Opening Remarks Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research
  Small Group Assignments Nancy M. Ostrove
9:30 - 9:45 Move to break out rooms  
9:45 - 12:00 Break out sessions  
12:00 - 1:15 Lunch  
1:15 - 2:45 Welcome Back
Results from small group breakout sessions
 
2:45 - 3:00 Closing Remarks